Archives

  • Vol.15 (2026)

    The International Journal of Cell Science and Biotechnology (IJCSB), ISSN 2320-7574, is a peer-reviewed, open-access international journal dedicated to advancing knowledge in cell science and biotechnology. Publishing since its inception, Volume 15 (2026) continues to serve as a reputable platform for researchers, academicians, and industry professionals worldwide. IJCSB publishes original research articles, reviews, case studies, and short communications covering cell biology, genomics, stem cell research, tissue engineering, and related disciplines. All submissions undergo a rigorous double-blind peer-review process to ensure academic excellence. The journal is committed to open access, ethical publishing, and fostering global scientific collaboration for the betterment of biomedical research and human health.

  • Vol.14 (2025)

    Volume 14 of IJCSB published pioneering research reflecting the most advanced frontiers of cell biology and biotechnology in 2025. Contributions on programmable cell therapies, including next-generation CAR-T and CAR-NK constructs, showcased remarkable progress in cellular immunotherapy. Research on epigenome editing, RNA-based gene regulation, and tissue-specific gene delivery using novel lipid nanoparticles featured prominently. Environmental biotechnology contributions addressed bioplastic synthesis, carbon capture using engineered microalgae, and biosensor development for pollution monitoring. Advances in human organ-on-chip technologies and vascularised organoid models were notably represented. The volume also included important agricultural biotechnology research on precision breeding and genomic selection. Volume 14 affirmed IJCSB's position as a credible, forward-looking open-access journal in the global life sciences community.

  • Vol.13 (2024)

    Volume 13 of the International Journal of Cell Science and Biotechnology captured a period of extraordinary scientific momentum. Research on next-generation gene therapies, including in vivo base editing and RNA interference therapeutics, showcased biotechnology's expanding clinical horizons. Single-cell multiomics studies illuminating developmental biology and disease mechanisms featured alongside advances in synthetic biology and metabolic engineering for biopharmaceutical production. Climate-resilient crop biotechnology and stress-tolerant transgenic plant research addressed global food security imperatives. Contributions on neurodegeneration at the cellular and molecular level reflected growing interest in Alzheimer's and Parkinson's disease mechanisms. Volume 13 demonstrated IJCSB's sustained relevance across fundamental and applied dimensions of contemporary cell science and biotechnology research globally.

  • Vol.12 (2023)

    Volume 12 reflected the convergence of artificial intelligence and cell biology that increasingly characterised research in 2023. Contributions addressing machine learning applications in genomic data analysis, protein structure prediction using AlphaFold-inspired approaches, and AI-assisted drug target identification illustrated biotechnology's computational turn. Research on spatial transcriptomics and multiomics integration enriched understanding of cellular heterogeneity in tissues. Organoid-based disease modelling for gastrointestinal and neurological conditions featured prominently. Animal biotechnology contributions on gene editing for livestock improvement and disease resistance demonstrated continued agricultural relevance. Volume 12 highlighted IJCSB's adaptability to rapidly shifting scientific methodologies, confirming the journal's commitment to publishing research at the forefront of cell science and biotechnology innovation.

  • Vol.11 (2022)

    Volume 11 of IJCSB embraced emerging research paradigms shaping the post-pandemic life sciences landscape. Contributions on immunological memory, B and T cell biology in the context of vaccination, and mucosal immunity reflected ongoing scientific interest in pandemic-derived insights. Research on exosome therapeutics, cell-based cancer immunotherapy, and CAR-T cell technology demonstrated the translational momentum in biotechnology. Environmental biotechnology research, including studies on plastic-degrading microorganisms and bioremediation using engineered cells, addressed global sustainability challenges. Advances in CRISPR base editing and prime editing appeared in several contributions, reflecting the rapidly evolving gene editing field. Volume 11 showcased IJCSB's continued capacity to publish cutting-edge, societally relevant research across its multidisciplinary scope.

  • Vo.10 (2021)

    Volume 10 marked a significant decennial milestone for the International Journal of Cell Science and Biotechnology, celebrating ten years of open-access publishing in the life sciences. This commemorative volume featured a broad retrospective of key advances in cell biology and biotechnology since the journal's founding. Research on mRNA-based therapeutics, inspired by COVID-19 vaccine successes, featured prominently alongside studies on long COVID cellular pathology and immune dysregulation. Advances in liquid biopsy technologies, cell-free DNA analysis, and precision oncology enriched the volume's translational content. Microbiome engineering and synthetic biology contributions demonstrated biotechnology's expanding boundaries. Volume 10 celebrated a decade of scientific contributions while charting ambitious directions for IJCSB's second decade of scholarly publication.

  • Vol.9 (2020)

    Volume 9 was published against the extraordinary backdrop of the global COVID-19 pandemic, which profoundly influenced the life sciences research landscape. The volume included contributions addressing coronavirus molecular biology, cell entry mechanisms of SARS-CoV-2, and innate immune responses at the cellular level, reflecting the scientific community's urgent pivoting toward pandemic-relevant research. Despite global disruptions, IJCSB maintained its publication schedule, demonstrating editorial resilience. Research on biosafety, vaccine platform technologies, and antiviral drug discovery enriched this volume considerably. Alongside pandemic-related content, fundamental research in cellular metabolism, mitochondrial biogenesis, and epigenetic programming continued to be published. Volume 9 affirmed IJCSB's relevance and adaptability during one of science's most challenging and significant years.

  • Vol.8 (2019)

    Volume 8 represented a milestone in IJCSB's publishing history, reflecting nearly a decade of contribution to the cell science and biotechnology literature. Research on CRISPR-Cas9 applications in animal and plant biotechnology featured strongly, as did studies on organoid technology and three-dimensional cell culture systems advancing in vitro disease modelling. Molecular studies on cell cycle regulation and apoptotic pathways contributed to the volume's oncological relevance. Biodiversity and conservation biotechnology research addressed pressing environmental challenges. The editorial team introduced enhanced manuscript submission guidelines and strengthened its plagiarism-screening protocols, reinforcing quality assurance. Volume 8 underscored IJCSB's sustained commitment to fostering rigorous, open-access scientific communication across the full spectrum of cell and molecular biology.

  • Vol.7 (2018)

    Volume 7 of the International Journal of Cell Science and Biotechnology saw continued growth in both submission quality and thematic diversity. Single-cell genomics and transcriptomics began influencing research directions published in this volume, reflecting global shifts in methodological sophistication. Research on cellular stress responses, particularly endoplasmic reticulum stress and the unfolded protein response, gained prominence. Contributions addressing biotechnological applications in veterinary medicine, including vaccine development and disease diagnostics using molecular tools, illustrated the applied scope of the journal. The volume also featured work on microbiome-host cell interactions, linking gut biology with systemic health. Volume 7 consolidated IJCSB's reputation as a responsive, peer-reviewed journal embracing both fundamental and applied dimensions of modern biotechnology.

  • Vol.6 (2017)

    Volume 6 reflected the accelerating pace of discovery in cell science and biotechnology, with research increasingly addressing translational applications. Studies on gene therapy vectors, targeted drug delivery using nanoparticles, and molecular diagnostics represented the journal's engagement with applied biotechnology. Contributions on stem cell banking and clinical applications of regenerative medicine grew in prominence. The volume also featured research on immunogenetics of livestock species, supporting India's agricultural biotechnology priorities. Advances in high-throughput proteomics and metabolomics enriched several contributions, reflecting broader methodological progress in the field. Volume 6 demonstrated IJCSB's evolution from a nascent journal into an established scholarly platform publishing research with clear scientific and societal relevance across cell biology and biotechnology.

  • Vol.5 (2016)

    Volume 5 of IJCSB captured exciting developments in cell biology and biotechnology during a transformative period for the life sciences. Research on epigenetic regulation, non-coding RNA biology, and exosome-mediated cell communication featured prominently, reflecting global research priorities. The volume also highlighted advances in animal genetic diversity conservation, an area of increasing importance given rising concerns about biodiversity loss. Molecular studies on actin dynamics, dynamin-mediated membrane fission, and sorting mechanisms contributed to understanding fundamental cellular processes. Fodder and feed biotechnology research demonstrated the journal's relevance to agricultural science communities. By Volume 5, IJCSB had established consistent publication frequency and continued attracting peer-reviewed contributions of growing scientific depth and breadth.

  • Vol.4 (2015)

    Volume 4 marked a period of growing maturity for the International Journal of Cell Science and Biotechnology, with increased submission rates reflecting the journal's expanding reputation. This volume showcased research on stem cell differentiation, gene expression regulation, and advances in CRISPR-based genome editing, which was revolutionising life sciences globally. Contributions on gut microbiome biotechnology and nutrigenomics addressed emerging intersections between nutrition, microbiology, and cell biology. Aquaculture biotechnology and marine ecosystem research also featured, broadening the journal's applied science dimensions. The editorial board strengthened its international reviewer network, improving turnaround times and peer-review quality. Volume 4 cemented IJCSB as a valuable resource for researchers across diverse biotechnology sub-disciplines.

1-12 of 15